logo

Revance Therapeutics, Inc. (RVNC)



Trade RVNC now with
  Date
  Headline
1/22/2019 4:10:02 PM Revance Announces Closing Of Public Offering Of Common Stock
1/17/2019 6:53:06 AM Revance Therapeutics Prices Public Offering Of 5.88 Mln Shares At $17.00 Per Share
12/4/2018 8:09:25 AM Revance Therapeutics Enters License Agreement With Fosun Pharma Industrial
10/11/2018 8:33:24 AM Revance Therapeutics Appoints Tobin Schilke As CFO
5/29/2018 7:02:27 AM Revance Therapeutics CFO Lauren Silvernail Resigns
2/28/2018 4:07:06 PM Mylan To Develop Biosimilar Of BOTOX Through Collaboration And License Agreement With Revance Therapeutics
1/9/2018 6:06:39 AM Hercules Capital Achieves More Than $880 Mln In New Commitments In 2017
1/8/2018 8:37:08 AM Revance Announces Interim Phase 2a Results For RT002 In Treating Plantar Fasciitis
12/28/2017 4:26:12 AM Watch These 6 Biotech Stocks
12/11/2017 4:10:28 PM Revance Announces Closing Of Public Offering Of Common Stock
12/7/2017 8:35:49 AM Revance Therapeutics Prices Public Offering Of 5.34 Mln Shares At $31.00/shr
12/5/2017 4:50:48 PM Revance Announces Proposed Public Offering Of Common Stock
12/5/2017 7:43:54 AM Revance Therapeutics, Trading Halted; Expected To Resume At 8:00 AM ET